Within certain limits, a National Academy panel says mitochondrial replacement techniques may be ethical.
The Chinese Academy of Sciences and the UK's Royal Society announce they will participate in the US National Academy of Sciences' international summit on gene editing.
The bodies will assemble an international committee to guide future research and have planned a summit this fall for experts to discuss the implications of the technology.
An Institute of Medicine committee member discusses its new report with Pharmalot's Ed Silverman.
An Institute of Medicine report addresses sharing clinical trial data.
The Institute of Medicine of the National Academy of Sciences has elected 70 new members including Lynda Chin, Stephen Quake, and Daniel Kastner.
By a GenomeWeb staff reporter
Foundation Medicine has added Brook Byers and Krishna Yeshwant to its board of directors as part of a Series A financing round (
DNAnexus has added two new board members: Krishna Yeshwant and Geoff Duyk.
The FDA expects 'strong public interest' regarding IOM's recommendations to make big changes to device review processes.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.